Neurosteroid allopregnanolone mediates anxiolytic effect of etifoxine in rats

Brain Research

Volumn 1184, Issue 1, 2007, Pages 193-201

  Ugale, Rajesh R ^b,c   Sharma, Ajaykumar N ^a,b   Kokare, Dadasaheb M ^a   Hirani, Khemraj ^a,d   Subhedar, Nishikant K ^a   Chopde, Chandrabhan T ^a,b  

^a RTM NAGPUR UNIVERSITY   (India)

^b India   (India)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Allopregnanolone; Anxiety; Etifoxine; Neurosteroids

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ANXIOLYTIC AGENT; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; BICUCULLINE; ETIFOXINE; FGIN 1-27; FINASTERIDE; INDOMETACIN; METYRAPONE; MUSCIMOL; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; PROGESTERONE; TRILOSTANE; UNCLASSIFIED DRUG;

ADRENALECTOMY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEROIDOGENESIS; TRANQUILIZING ACTIVITY;

ADRENALECTOMY; ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BICUCULLINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG INTERACTIONS; ENZYME INHIBITORS; GABA AGONISTS; GABA ANTAGONISTS; MALE; MAZE LEARNING; MUSCIMOL; OXAZINES; PREGNANOLONE; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME;

RATTUS;

EID: 36349004814     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.09.041     Document Type: Article

References (56)

1. Akwa Y., Purdy R.H., Koob G.F., and Britton K.T. The amygdala mediates the anxiolytic-like effect of the neurosteroid in the rat. Behav. Brain Res. 106 (1999) 119-125
2. Almeida R.M., Giovenardi M., Damra A., Frey R.M., and Rasia-Filho A.A. Plus-maze following the microinjection of muscimol into the dorsal periaqueductal gray of the rat. Rev. Bras. Psiquiatr. 28 (2006) 80-82
3. Bertoglio L.J., and Carobrez A.P. Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze. Pharmacol. Biochem. Behav. 72 (2002) 449-455
4. Beyer C., Gonzalez-Flores O., Ramirez-Orduna J.M., and Gonzalez-Mariscal G. Indomethacin inhibits lordosis induced by ring-a reduced progestins: possible role of 3α-oxoreduction in progestin-facilitated lordosis. Horm. Behav. 35 (1999) 1-8
5. Birzniece V., Türkmen S., Lindblad C., Zhu D., Johansson I.M., Bäckström T., and Wahlström G. GABA(A) receptor changes in acute allopregnanolone tolerance. Eur. J. Pharmacol. 535 (2006) 125-134
6. Bitran D., Hilvers R.J., and Kellogg C.K. Ovarian endocrine status modulates the anxiolytic potency of diazepam and the efficacy of γ-aminobutyric acid-benzodiazepine receptor mediated chloride ion transport. Behav. Neurosci. 105 (1991) 651-660
7. Bitran D., Purdy R., and Kellogg C. Anxiolytic effect of progesterone is associated with increases in cortical 3α, 5α-THP, pregnanolone and GABAA receptor function. Pharmacol. Biochem. Behav. 45 (1993) 423-428
8. Blurton-Jones M.M., Roberts J.A., and Tuszynski M.H. Estrogen receptor immunoreactivity in the adult primate brain: neuronal distribution and association with P75, trkA, and choline acetyltransferase. J. Comp. Neurol. 405 (1999) 529-542
9. Boissier J.R., Simon P., Zaczinska M., and Fichelle J. Experimental psychopharmacologic study of a new psychotropic drug, 2-ethylamino-6-chloro-4-methyl-4-phenyl-4H-3,1-benzoxazine. Therapie 27 (1972) 325-338
10. Campo-Soria C., Chang Y., and Weiss D.S. Mechanism of action of benzodiazepines on GABAA receptors. Br. J. Pharmacol. 148 (2006) 984-990
11. Concas A., Mostallino M.C., Porcu P., Barbaccia M.L., Trabucchi M., Purdy R.H., Grisenti P., and Biggio G. Role of allopregnanolone in the plasticity of γ-aminobutyric acid type-A receptor in rat brain during pregnancy and after delivery. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13284-13289
12. Corpechot C., Robel P., Axelson M., Sjovall J., and Baulieu E.E. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc. Natl. Acad. Sci. U. S. A. 78 (1981) 4704-4707
13. Drafts B.C., and Fisher J.L. Identification of structures within GABAA receptor alpha subunits that regulate the agonist action of pentobarbital. J. Pharmacol. Exp. Ther. 318 (2006) 1094-1101
14. Finn D.A., Phillips T.J., Okorn D.M., Chester J.A., and Cunningham C.L. Rewarding effect of the neuroactive steroid 3 alpha-hydroxy-5 alpha-pregnan-20-one in mice. Pharmacol. Biochem. Behav. 56 (1997) 261-264
15. Follesa P., Biggio F., Mancuso L., Cabras S., Caria S., Gorini G., Manca A., Orru A., and Biggio G. Ethanol withdrawal-induced up-regulation of the alpha2 subunit of the GABAA receptor and its prevention by diazepam or gamma-hydroxybutyric acid. Mol. Brain Res. 120 (2004) 130-137
16. Hamon A., Morel A., Hue B., Verleye M., and Gillardin J.M. The modulatory effects of the anxiolytic etifoxine on GABA(A) receptors are mediated by the beta subunit. Neuropharmacology 45 (2003) 293-303
17. Harrison N.L., and Simmonds M.A. Modulation of GABA receptor complex by a steroid anesthetic. Brain Res. 323 (1984) 284-293
18. Harrison N.L., Majewska M.D., Harrington J.W., and Barkes J.L. Structure activity relationships for steroid interaction with the gamma aminobutyric acid receptor complex. J. Pharmacol. Exp. Ther. 241 (1987) 346-353
19. Hirani K., Khisti R.T., and Chopde C.T. Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3 alpha-hydroxy-5 alpha-pregnan-20-one. Neuropharmacology 43 (2002) 1339-1350
20. Hirani K., Sharma A.N., Jain N.S., Ugale R.R., and Chopde C.T. Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5 alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats. Psychopharmacology 180 (2005) 267-278
21. Jain M.R., Khan F.A., Krishna N.S., and Subhedar N. Intracranial metyrapone stimulates CRF-ACTH axis in the teleost, Clarias batrachus: possible role of neurosteroids. NeuroReport 5 (1994) 2093-2096
22. Khisti R.T., Deshpande L.S., and Chopde C.T. The neurosteroid 3α-hydroxy-5α-pregnan-20-one affects dopamine-mediated behavior in rodents. Psychopharmacology 161 (2002) 120-128
23. Klatzkin R.R., Morrow A.L., Light K.C., Pedersen C.A., and Girdler S.S. Associations of histories of depression and PMDD diagnosis with allopregnanolone concentrations following the oral administration of micronized progesterone. Psychoneuroendocrinology 31 (2006) 1208-1219
24. Kokare D.M., Chopde C.T., and Subhedar N.K. Participation of alpha-melanocyte stimulating hormone in ethanol-induced anxiolysis and withdrawal anxiety in rats. Neuropharmacology 51 (2006) 336-345
25. Kokate T.G., Banks M.K., Magee T., Yamaguchi S., and Rogawski M.A. Finasteride, a 5α-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice. J. Pharmacol. Exp. Ther. 288 (1999) 679-684
26. Korneyev A., Pan B.S., Polo A., Romeo E., Guidotti A., and Costa E. Stimulation of brain pregnenolone synthesis by mitochondrial diazepam binding inhibitor receptor ligands in vivo. J. Neurochem. 61 (1993) 1515-1524
27. Korpi E.R., Grunder G., and Luddens H. Drug interactions at GABAA receptors. Prog. Neurobiol. 67 (2002) 113-159
28. Lambert J.J., Belelli D., Hill-Venning C., and Peters J.A. Neurosteroids and GABAA receptor function. Trends Pharmacol. Sci. 16 (1995) 295-303
29. Lambert J.J., Belelli D., Harney S.C., Peters J.A., and Frenguelli B.G. Modulation of native and recombinant GABAA receptors by endogenous and synthetic neuroactive steroids. Brains Res. Rev. 37 (2001) 68-80
30. Micallef J., Soubrouillard C., Guet F., Le Guern M.E., Alquier C., Bruguerolle B., and Blin O. A double blind parallel group placebo controlled comparison of sedative and amnesic effects of etifoxine and lorazepam in healthy subjects. Fundam. Clin. Pharmacol. 15 (2001) 209-216
31. Nguyen N., Fakra E., Pradel V., Jouve E., Alquier C., Le Guern M.E., Micallef J., and Blin O. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice. Hum. Psychopharmacol. Clin. Exp. 21 (2006) 139-149
32. N-Wihlback A.C., Sundstrom-Poromaa I., and Backstrom T. Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders. Psychopharmacology 186 (2006) 388-401
33. Palmer A.A., Miller M.N., McKinnon C.S., and Phillips T.J. Sensitivity to the locomotor stimulant effects of ethanol and allopregnanolone shares common genetic influence. Behav. Neurosci. 116 (2002) 126-137
34. Paoletti A.M., Romagnino S., Contu R., Orru M.M., Marotto M.F., Zedda P., Lello S., Biggio G., Concas A., and Melis G.B. Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity. Psychoneuroendocrinology 31 (2006) 485-492
35. Paul S.M., and Purdy R.H. Neuroactive steroids. FASEB J. 6 (1992) 2311-2322
36. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, San Diego
37. Pellow S., Chopin P., File S.E., and Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14 (1985) 149-167
38. Petralia S.M., Jahagirdar V., and Frye C.A. Inhibiting biosynthesis and/or metabolism of progestins in the ventral tegmental area attenuates lordosis of rats in behavioural oestrus. J. Neuroendocrinol. 17 (2005) 545-552
39. Pinna G., Costa E., and Guidotti A. Changes in brain testosterone and allopregnanolone biosynthesis elicit aggressive behavior. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2135-2140
40. Potts G.O., Creange J.E., Hardomg H.R., and Schane H.P. Trilostane, a orally active inhibitor of steroid biosynthesis. Steroids 32 (1978) 257-267
41. Rasmusson A.M., Pinna G., Paliwal P., Weisman D., Gottschalk C., Charney D., Krystal J., and Guidotti A. Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder. Biol. Psychiatry 60 (2006) 704-713
42. Romeo E., Auta J., Kozikowski A.P., Ma D., Papadopoulos V., Puia G., Costa E., and Guidotti A. 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR). J. Pharmacol. Exp. Ther. 262 (1992) 971-978
43. Romeo E., Cavallaro S., Korneyev A., Kozikowski A.P., Ma D., Polo A., Costa E., and Guidotti A. Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex. J. Pharmacol. Exp. Ther. 287 (1993) 462-471
44. Rupprecht R., Stohle A., Hermann B., di Michele F., Spaletta G., Pasini A., Holsboer F., and Romeo E. Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers. Biol. Psychiatry 44 (1998) 912-914
45. Schlichter R., Rybalchenko V., Poisbeau P., Verleye M., and Gillardin J.M. Modulation of GABAergic synaptic transmission by the non-benzodiazepine anxiolytic etifoxine. Neuropharmacology 39 (2000) 1523-1535
46. Semeniuk T., Jhangri G.S., Le Guern M.E., and Melledo J.M. Neuroactive steroid levels in patients with generalized anxiety disorder. J. Neuropsychiatry Clin. Neurosci. 13 (2001) 396-398
47. Sharma A.N., Chopde C.T., Hirani K., Kokare D.M., and Ugale R.R. Chronic progesterone treatment augments while dehydroepiandrosterone sulphate prevents tolerance to ethanol anxiolysis and withdrawal anxiety in rats. Eur. J. Pharmacol. 567 (2007) 211-222
48. Sigel E., and Buhr A. The benzodiazepine binding site of GABAA receptors. Trends Pharmacol. Sci. 18 (1997) 425-429
49. Ugale R.R., Mittal N., Hirani K., and Chopde C.T. Essentiality of central GABAergic neuroactive steroid allopregnanolone for anticonvulsant action of fluoxetine against pentylenetetrazole-induced seizures in mice. Brain Res. 1023 (2004) 102-111
50. Ugale R.R., Hirani K., Morelli M., and Chopde C.T. Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents. Neuropsychopharmacology 29 (2004) 1597-1609
51. VanDoren M.J., Matthews D.B., Janis G.C., Grobin A.C., Devaud L.L., and Morrow A.L. Neuroactive steroid 3alpha-hydroxy-5alpha-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol. J. Neurosci. 20 (2000) 1982-1989
52. Verleye M., and Gillardin J.-M. Effects of etifoxine on stress-induced hyperthermia, freezing behavior and colonic motor activation in rats. Physiol. Behav. 82 (2004) 891-897
53. Verleye M., Schlichter R., and Gillardin J.-M. Interaction of etifoxine with the chloride channel coupled to the GABAA receptor complex. NeuroReport 10 (1999) 3207-3210
54. Verleye M., Schlichter R., Neliat G., Pansart Y., and Gillardin J.M. Functional modulation of gamma-amino acid A receptor by etifoxine and allopregnanolone in rodents. Neurosci. Lett. 301 (2001) 191-194
55. Verleye M., Pansart Y., and Gillardin J.M. Effects of etifoxine on ligand binding to GABAA receptors in rodents. Neurosci. Res. 44 (2002) 167-172
56. Verleye M., Akwa Y., Liere P., Ladurelle N., Pianos A., Eychenne B., Schumacher M., and Gillardin J.-M. The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain. Pharmacol. Biochem. Behav. 82 (2005) 712-720